Chester County News and Community Website
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: “NXGL”) this week announced financial results for the fourth quarter and full year ended December 31, 2022.
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its financial results for the twelve months that ended December 31, 2022, and other recent developments.
Virpax Pharmaceuticals Reports 2022 Year-End Results Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) recently announced financial results for the year ended December 31, 2022. Additionally, the Company announced a portfolio prioritization and capital allocation strategy …
Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) this week reported financial results for the fourth quarter and full year that ended December 31, 2022.
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) reported financial results for the fourth quarter that ended December 31, 2022, and provided a corporate update.
Immunome Reports Fourth Quarter and Full Year 2022 Financial Results Read More
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX) recently announced financial results for the twelve months ended December 31, 2022, and provided a business update.
Onconova Therapeutics Reports Full Year 2022 Financial Results Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) recently announced results for its fourth quarter (Q4’22) and full-year periods ended December 31, 2022, with higher revenue, gross profit and improved …
Acorn Energy Reports Revenue Growth in Q4 and Fiscal Year 2022 Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) recently reported financial results and business highlights for the full-year ended December 31, 2022.
Century Therapeutics Reports Full Year 2022 Financial Results Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) recently reported financial results for the fourth quarter and full year that ended December 31, 2022, and provided a business update.
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) this week reported its financial results for the fiscal year ended December 31, 2022, and provided a corporate update.
Prelude Therapeutics Reports Full Year 2022 Financial Results Read More